Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.38% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.38% | -- | -- | -- | -- |
| Cost of Revenue | 46.35% | -- | -- | -- | -- |
| Gross Profit | 65.11% | -- | -- | -- | -- |
| SG&A Expenses | 67.36% | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.38% | -- | -- | -- | -- |
| Operating Income | -63.11% | -- | -- | -- | -- |
| Income Before Tax | -55.64% | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.64% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.64% | -- | -- | -- | -- |
| EBIT | -63.11% | -- | -- | -- | -- |
| EBITDA | -62.74% | -- | -- | -- | -- |
| EPS Basic | 66.98% | -- | -- | -- | -- |
| Normalized Basic EPS | 65.95% | -- | -- | -- | -- |
| EPS Diluted | 66.98% | -- | -- | -- | -- |
| Normalized Diluted EPS | 65.95% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 216.52% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 216.52% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |